Brief: Aroa Biosurgery Posts FY26 Prelim Total Revenue Of NZ$104 Million
30/04/2026 02:52
April 30 (Reuters) - Aroa Biosurgery Ltd ARX.AX: FY26 PRELIM TOTAL REVENUE OF NZ$104 MILLION FY26 PRELIM NORMALISED EBITDA OF NZ$11-12 MILLION Further company coverage: ARX.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aroa Biosurgery
See all newsAustralia-listed Aroa Biosurgery climbs as annual earnings beat guidance
Brief: Aroa Biosurgery Posts Adjusted EBITDA Of NZ$12.6 Million
Aroa Biosurgery climbs as prelim annual results beat outlook
Brief: Aroa Biosurgery Posts FY26 Prelim Total Revenue Of NZ$104 Million
Brief: Aroa Biosurgery Says Expects FY26 Revenue At Upper End Of NZ$92-100 Million